loader
Please Wait
Applying Filters...

Information, Expiry & Status of FDA Orange Book Patents covering Liraglutide

Menu
$ API Ref.Price (USD/KG) : 950,374Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 33NOVO

02 8NOVO NORDISK INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

LIRAGLUTIDE

US Patent Number : 9968659

Drug Substance Claim :

Drug Product Claim :

Application Number : 206321

Patent Use Code : U-2438

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-01-09

blank

02

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

LIRAGLUTIDE

US Patent Number : 9968659

Drug Substance Claim :

Drug Product Claim :

Application Number : 22341

Patent Use Code : U-2313

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-01-09

blank

03

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

LIRAGLUTIDE

US Patent Number : RE46363

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206321

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-03

blank

04

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

LIRAGLUTIDE

US Patent Number : 8114833

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206321

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-08-13

blank

05

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

LIRAGLUTIDE

US Patent Number : 10220155

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206321

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-07-17

blank

06

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

LIRAGLUTIDE

US Patent Number : 9861757

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206321

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-01-20

blank

07

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

LIRAGLUTIDE

US Patent Number : 9265893

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22341

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-09-23

blank

08

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

LIRAGLUTIDE

US Patent Number : 8114833

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22341

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-08-13

blank

09

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

LIRAGLUTIDE

US Patent Number : 11097063

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206321

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-07-17

blank

10

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

LIRAGLUTIDE

US Patent Number : 9616180

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206321

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-01-20

blank